SCHEMBL44730

SCHEMBL44730

c1ccc2c(c1)c1ccccc1n2CCc1ccc2[nH]c3ccc(CCn4c5ccccc5c5ccccc54)cc3c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.47
BCHE P06276 1/20 0.43
ACHE P22303 1/20 0.43
SMPD1 P17405 3/20 0.43
PARP1 P09874 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP19A1 P11511 1/20 0.42
AHR P35869 1/20 0.41
TERT O14746 1/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
FABP4 P15090 2/20 0.41
FABP5 Q01469 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24631978 0.82 CYP19A1 (0.53) HDAC6CYP1A2CYP2C19SMN1; SMN2CYP19A1
SCHEMBL14853003 0.82 PRMT5 (0.39) HDAC6BCHEACHESMPD1PARP1
SCHEMBL19768708 0.77 AHR (0.59) AHRKDM4EMAPTMEN1ALDH1A1
SCHEMBL14839698 0.77 HDAC6 (0.50) HDAC6BCHEACHESMPD1CYP1A2
SCHEMBL11209828 0.74 BCHE (0.67) HDAC6BCHEACHESMPD1CYP1A2
SCHEMBL29643279 0.74 BCHE (0.67) HDAC6BCHEACHESMPD1CYP1A2
SCHEMBL14839671 0.73 PTGER4 (0.47) HDAC6BCHEACHESMPD1KDM4E
SCHEMBL869229 0.72 AHR (0.53) CYP1A2CYP2C19SMN1; SMN2AHRKDM4E
SCHEMBL2311195 0.72 AHR (0.53) RAB9ASMN1; SMN2AHRKDM4EMAPT
SCHEMBL12997524 0.72 KIF11 (0.59) RAB9ASMN1; SMN2AHRKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9598450-B2 Emissive compounds for organic light-emitting diodes NITTO DENKO CORPORATION (JP) 2017-03-21 US disclosed
US-9598450-B2 Emissive compounds for organic light-emitting diodes NITTO DENKO CORPORATION (JP) 2017-03-21 US disclosed
US-20130087772-A1 EMISSIVE COMPOUNDS FOR ORGANIC LIGHT-EMITTING DIODES NITTO DENKO CORPORATION (JP) 2013-04-11 US disclosed
US-20130087772-A1 EMISSIVE COMPOUNDS FOR ORGANIC LIGHT-EMITTING DIODES NITTO DENKO CORPORATION (JP) 2013-04-11 US disclosed
WO-2011149500-A1 EMISSIVE COMPOUNDS FOR ORGANIC LIGHT-EMITTING DIODES NITTO DENKO CORPORATION (JP) 2011-12-01 WO disclosed
WO-2011149500-A1 EMISSIVE COMPOUNDS FOR ORGANIC LIGHT-EMITTING DIODES NITTO DENKO CORPORATION (JP) 2011-12-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130087772-A1 EMISSIVE COMPOUNDS FOR ORGANIC LIGHT-EMITTING DIODES CRY2, PPOX, CRY1 HDAC6 3609/4885BCHE 3538/4885ACHE 505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.